Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

Presentation ESC 2025

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

Presenter: Mohamed Abdel-Wahab

August 29, 2025

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

Todd Neale

August 31, 2024

News Conference News ESC 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

Todd Neale

August 31, 2023

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2021

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

Yael L. Maxwell

September 02, 2021

News Conference News ESC 2021

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

Todd Neale

September 01, 2021

News Conference News ESC 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

Shelley Wood

August 31, 2021

News Conference News ESC 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Shelley Wood

August 28, 2021

News Conference News ESC 2018

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

L.A. McKeown

September 04, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

Advertisement

ESC/EACTS Release New Valvular Heart Disease Guidelines

DOUBLE-CHOICE: A 2x2 Randomized Trial of Peri-interventional Anesthesia Strategies and Self-Expanding Valve Types in Patients Undergoing Transcatheter Aortic Valve Implantation

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Trial Challenges Continuation of Oral Anticoagulants During TAVI

ESC Endocarditis Guidelines Get First Update in 8 Years

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Guidelines for the Management of Valvular Heart Disease

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content